PF awareness
September 11, 2012
PULMONARY fibrosis kills as many
people worldwide per annum as
breast cancer, according to the
Coalition for Pulmonary Fibrosis.
The statement comes in
conjunction with the launch of
Pulmonary Fibrosis Awareness
Month this September.
Pulmonary Fibrosis is a lung
disorder characterised by a
progressive scarring, known as
fibrosis, and deterioration of the
lungs, which slowly robs its victims
of their ability to breathe.
Currently there is no known cause
or cure for the condition, and it is
estimated that around two-thirds
of patients die within five years of
diagnosis.
"The search for an effective
treatment for pulmonary fibrosis
remains a challenge to the
academic scientific community,”
said Dr Marvin Schwarz, Professor
of Pulmonary Medicine at the
Division of Pulmonary Sciences and
Critical Care Medicine at the
University of Colorado in Denver.
“New and expected discoveries
will hopefully lead to individualised
therapies.
“All of us in the pulmonary
community welcome the call for
increased research funding and we
know that the answers are closer
each day,” he added.
See www.coalitionforpf.org.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Sep 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Sep 12
